STOCK TITAN

Exscientia to Present at Upcoming Investor Conferences in March

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Exscientia plc (Nasdaq: EXAI) announced participation in several investor conferences in March 2023. Key events include the Morgan Stanley EMEA HealthTech Conference on March 1, Cowen 43rd Annual Healthcare Conference on March 7 at 11:10 a.m. EST, and the Barclays Global Healthcare Conference on March 15 at 3:05 p.m. EDT. Live webcasts will be accessible on Exscientia's website, with archived replays available for 30 days post-event. Exscientia utilizes AI in drug development, aiming to enhance patient outcomes through a precision medicine approach.

Positive
  • None.
Negative
  • None.

OXFORD, England--(BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) today announced that members of management will participate in the following upcoming investor conferences in March:

  • Morgan Stanley EMEA HealthTech Conference. Management will participate in virtual investor meetings on Wednesday, March 1, 2023
  • Cowen 43rd Annual Healthcare Conference. Formal presentation on Tuesday, March 7, 2023, at 11:10 a.m. EST (4:10 p.m. GMT) in Boston, Massachusetts
  • Barclays Global Healthcare Conference. Fireside chat on Wednesday, March 15, 2023, at 3:05 p.m. EDT (7:05 p.m. GMT) in Miami, Florida

Live webcasts of the company presentations will be available on the Company’s website, under the “Investors & Media” section at www.investors.exscientia.ai. Archived replays of the webcasts will be available for approximately 30 days following the presentation.

About Exscientia

Exscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our internal pipeline is focused on leveraging our precision medicine platform in oncology, while our partnered pipeline broadens our approach to other therapeutic areas. By pioneering a new approach to medicine creation, we believe the best ideas of science can rapidly become the best medicines for patients.

Visit us at https://www.exscientia.ai or follow us on Twitter @exscientiaAI.

Investor Relations Contact:

Sara Sherman

investors@exscientia.ai



Media Contact:

Oliver Stohlmann

media@exscientia.ai

Source: Exscientia plc

FAQ

What conferences will Exscientia (EXAI) participate in March 2023?

Exscientia will participate in the Morgan Stanley EMEA HealthTech Conference on March 1, Cowen 43rd Annual Healthcare Conference on March 7, and Barclays Global Healthcare Conference on March 15.

When is Exscientia's formal presentation at the Cowen Conference?

Exscientia's formal presentation at the Cowen 43rd Annual Healthcare Conference is scheduled for March 7, 2023, at 11:10 a.m. EST.

What time is the fireside chat at the Barclays Conference for Exscientia (EXAI)?

The fireside chat at the Barclays Global Healthcare Conference will take place on March 15, 2023, at 3:05 p.m. EDT.

Where can I watch Exscientia's conference presentations?

You can watch Exscientia's conference presentations live on their website under the 'Investors & Media' section.

How does Exscientia (EXAI) utilize AI in its business?

Exscientia uses AI to discover and develop drugs, aiming to improve patient outcomes through a precision medicine platform.

Exscientia Plc American Depositary Shares

NASDAQ:EXAI

EXAI Rankings

EXAI Latest News

EXAI Stock Data

633.18M
95.77M
25.9%
20.81%
2.15%
Biotechnology
Healthcare
Link
United States of America
Oxford